{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:38:33Z","timestamp":1763707113931,"version":"3.44.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,22]]},"DOI":"10.7759\/cureus.92973","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:29:32Z","timestamp":1758598172000},"source":"Crossref","is-referenced-by-count":1,"title":["Immune Checkpoint Inhibitor-Induced Myocarditis, Myositis, and Concern for 3-Ms Syndrome in a Patient With Metastatic Melanoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Jad","family":"Daw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Padron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishaan","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter","family":"Stecko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdo","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13931","article-title":"Immune checkpoint inhibitor-induced myocarditis with myositis\/myasthenia gravis overlap syndrome: A systematic review of cases","volume":"26","author":"Pathak R","year":"2021","unstructured":"Pathak R, Katel A, Massarelli E, Villaflor VM, Sun V, Salgia R. Immune checkpoint inhibitor-induced myocarditis with myositis\/myasthenia gravis overlap syndrome: A systematic review of cases. Oncologist. 2021, 26:1052-61. 10.1002\/onco.13931","journal-title":"Oncologist"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14946","article-title":"Nivolumab-associated myositis myocarditis and myasthenia and anti-striated muscle antibodies","volume":"50","author":"Fazal M","year":"2020","unstructured":"Fazal M, Prentice DA, Kho LK, Fysh E. Nivolumab-associated myositis myocarditis and myasthenia and anti-striated muscle antibodies. Intern Med J. 2020, 50:1003-6. 10.1111\/imj.14946","journal-title":"Intern Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14161794","article-title":"Myocarditis, myositis, and myasthenia gravis overlap syndrome associated with immune checkpoint inhibitors: A systematic review","volume":"14","author":"Lipe DN","year":"2024","unstructured":"Lipe DN, Qdaisat A, Krishnamani PP, et al.. Myocarditis, myositis, and myasthenia gravis overlap syndrome associated with immune checkpoint inhibitors: A systematic review. Diagnostics. 2024, 14:1794. 10.3390\/diagnostics14161794","journal-title":"Diagnostics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-41008-7_15","article-title":"Immune checkpoint inhibitors (ICIs)-related cardiotoxicity","volume":"1244","author":"Zarifa A","year":"2020","unstructured":"Zarifa A, Lopez-Mattei J, Palaskas N, Iliescu C, Durand JB, Kim PY. Immune checkpoint inhibitors (ICIs)-related cardiotoxicity. Adv Exp Med Biol. 2020, 1244:277-85. 10.1007\/978-3-030-41008-7_15","journal-title":"Adv Exp Med Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170804143706","article-title":"Immune checkpoint inhibitors: Basics and challenges","volume":"26","author":"Li B","year":"2019","unstructured":"Li B, Chan HL, Chen P. Immune checkpoint inhibitors: Basics and challenges. Curr Med Chem. 2019, 26:3009-25. 10.2174\/0929867324666170804143706","journal-title":"Curr Med Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80136","article-title":"Tumor response to immune-oncology therapy despite high-dose steroid intervention in a patient with papillary renal cell carcinoma and immune-related myasthenia gravis","volume":"17","author":"Mazahreh L","year":"2025","unstructured":"Mazahreh L, Mazahreh F, Alqtishat B, Safar M. Tumor response to immune-oncology therapy despite high-dose steroid intervention in a patient with papillary renal cell carcinoma and immune-related myasthenia gravis. Cureus. 2025, 17:e80136. 10.7759\/cureus.80136","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0130","article-title":"Immune checkpoint inhibitor-associated myocarditis","volume":"23","author":"Ganatra S","year":"2018","unstructured":"Ganatra S, Neilan TG. Immune checkpoint inhibitor-associated myocarditis. Oncol. 2018, 23:879-86. 10.1634\/theoncologist.2018-0130","journal-title":"Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa051","article-title":"Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis","volume":"41","author":"Zhang L","year":"2020","unstructured":"Zhang L, Awadalla M, Mahmood SS, et al.. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. Eur Heart J. 2020, 41:1733-43. 10.1093\/eurheartj\/ehaa051","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa214","article-title":"A different type of acute myocarditis: A case report of acute autoimmune myocarditis mediated by anti-PD-1 T lymphocyte receptor (pembrolizumab)","volume":"4","author":"Salido Iniesta M","year":"2020","unstructured":"Salido Iniesta M, L\u00f3pez L\u00f3pez L, Carreras Costa F, Sionis A. A different type of acute myocarditis: A case report of acute autoimmune myocarditis mediated by anti-PD-1 T lymphocyte receptor (pembrolizumab). Eur Heart J Case Rep. 2020, 4:1-6. 10.1093\/ehjcr\/ytaa214","journal-title":"Eur Heart J Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001874","article-title":"Immune checkpoint inhibitor-associated myositis: A distinct form of inflammatory myopathy","volume":"28","author":"Saygin D","year":"2022","unstructured":"Saygin D, Ghosh N, Reid P. Immune checkpoint inhibitor-associated myositis: A distinct form of inflammatory myopathy. J Clin Rheumatol. 2022, 28:367-73. 10.1097\/RHU.0000000000001874","journal-title":"J Clin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5050","article-title":"Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single-center case series","volume":"12","author":"Longinow J","year":"2023","unstructured":"Longinow J, Zmaili M, Skoza W, et al.. Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single-center case series. Cancer Med. 2023, 12:2281-9. 10.1002\/cam4.5050","journal-title":"Cancer Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaf019","article-title":"Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: A case report","volume":"9","author":"Wadden E","year":"2025","unstructured":"Wadden E, Lai C, Grivas P, et al.. Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: A case report. Eur Heart J Case Rep. 2025, 9:ytaf019. 10.1093\/ehjcr\/ytaf019","journal-title":"Eur Heart J Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-024-09918-6","article-title":"Steroid-refractory myocarditis induced by immune checkpoint inhibitor responded to infliximab: Report of two cases and literature review","volume":"24","author":"Tan S","year":"2024","unstructured":"Tan S, Qi C, Zeng H, et al.. Steroid-refractory myocarditis induced by immune checkpoint inhibitor responded to infliximab: Report of two cases and literature review. Cardiovasc Toxicol. 2024, 24:1174-91. 10.1007\/s12012-024-09918-6","journal-title":"Cardiovasc Toxicol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/409857-immune-checkpoint-inhibitor-induced-myocarditis-myositis-and-concern-for-3-ms-syndrome-in-a-patient-with-metastatic-melanoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:29:33Z","timestamp":1758598173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/409857-immune-checkpoint-inhibitor-induced-myocarditis-myositis-and-concern-for-3-ms-syndrome-in-a-patient-with-metastatic-melanoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.92973","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}